全州神经科住院全身和大脑18F-氧葡萄糖正子发射断层扫描利用模式显示了优化途径
Rudy Goh1, Jamie Bellinge2,3,4, Haelynn Gim3
1Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
Internal medicine journal
|December 14, 2024
概括
获得18F-氧葡萄糖正子发射断层扫描 (18F-FDG PET) 影响神经病学的住院护理. 有限的现场访问减少了PET的使用,增加了等待时间,突出了需要改进的可访问性策略.
科学领域:
- 神经学 神经学
- 核医学是一种核医学.
- 放射学 放射学是一门学科.
背景情况:
- 18F-氧葡萄糖正子发射断层扫描 (18F-FDG PET) 在神经学中提供了宝贵的诊断见解.
- 然而,进入PET成像设施的挑战可能会限制其临床应用.
研究的目的:
- 评估现场访问18F-FDG PET对其用于神经病学住院患者的利用和及时性的影响.
- 在全州卫生保健系统中识别PET成像访问的差异.
主要方法:
- 一项为期两年的全州研究分析了神经病患者住院住院情况.
- 收集的数据包括PET扫描利用率和从入院到扫描的时间.
- 在现场拥有和没有PET能力的设施之间进行了比较.
主要成果:
- 近28%的神经科住院患者在PET扫描上显示出显著异常.
- 缺乏现场PET接入的设施的PET利用率明显较低 (P < 0.01).
- 在没有现场PET的场所的患者经历了从入院到成像的较长延迟 (P = 0.018).
结论:
- 18F-FDG PET在现场的可用性对于神经病学的及时和公平的患者护理至关重要.
- 提高PET成像可访问性的策略是必要的,以克服当前的障碍.
- 对改善PET接入的进一步研究对于神经学住院患者群体是有必要的.
相关概念视频
Positron Emission Tomography
4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
81
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
81


![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)